Position history for GLENVIEW CAPITAL MANAGEMENT, LLC's holdings in MYRIAD GENETICS INC
GLENVIEW CAPITAL MANAGEMENT, LLC holds 4.6M shares of MYGN (MYRIAD GENETICS INC), worth $28.2M as of 2025-Q4. MYGN represents 0.6% of GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio.
Current Value
$28.2M
Current Shares
4.6M
Total Value Change
-$63.5M
Total Shares Change
+838,975
Other major holders of MYGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 4.6M |
0.0% |
| $28.2M |
| 0.6% |
| $6.17 |
0 |
| 2025-Q3 | Unchanged | 4.6M | 0.0% | $33.2M | 0.7% | $7.24 | 0 |
| 2025-Q2 | Increased | 4.6M | +17.6% | $24.4M | 0.7% | $5.25 | 48 |
| 2025-Q1 | Decreased | 3.9M | -6.2% | $34.6M | 0.9% | $8.88 | 0 |
| 2024-Q4 | Increased | 4.2M | +229.6% | $57M | 1.4% | $13.63 | 76 |
| 2024-Q3 | Decreased | 1.3M | -66.3% | $34.6M | 0.7% | $26.46 | 0 |
| 2024-Q2 | Decreased | 3.7M | -24.2% | $91.7M | 1.8% | $24.46 | 0 |